AGTR2 and hypertensive disorder: A latest animal experiment showed that Roxadustat can alleviate hypertension and organ damage through upregulation of angiotensin receptor type 2 (AGTR2) and endothelial NO synthase (eNOS), downregulation of angiotensin receptor type 1 (AGTR1), and inhibition of oxidative stress [29].